Abstract:Gene therapy has long held promise to correct a variety of human diseases and defects. Discovery of the Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR), the mechanism of the CRISPR-based prokaryotic adaptive immune system (CRISPR-associated system, Cas), and its repurposing into a potent gene editing tool has revolutionized the field of molecular biology and generated excitement for new and improved gene therapies. Additionally, the simplicity and flexibility of the CRISPR/Cas9 site-specific nuclease system has led to its widespread use in many biological research areas including development of model cell lines, discovering mechanisms of disease, identifying disease targets, development of transgene animals and plants, and transcriptional modulation. In this review, we present the brief history and basic mechanisms of the CRISPR/Cas9 system and its predecessors (ZFNs and TALENs), lessons learned from past human gene therapy efforts, and recent modifications of CRISPR/Cas9 to provide functions beyond gene editing. We introduce several factors that influence CRISPR/Cas9 efficacy which must be addressed before effective in vivo human gene therapy can be realized. The focus then turns to the most difficult barrier to potential in vivo use of CRISPR/Cas9, delivery. We detail the various cargos and delivery vehicles reported for CRISPR/Cas9, including physical delivery methods (e.g. microinjection; electroporation), viral delivery methods (e.g. adeno-associated virus (AAV); full-sized adenovirus and lentivirus), and non-viral delivery methods (e.g. liposomes; polyplexes; gold particles), and discuss their relative merits. We also examine several technologies that, while not currently reported for CRISPR/Cas9 delivery, appear to have promise in this field. The therapeutic potential of CRISPR/Cas9 is vast and will only increase as the technology and its delivery improves.

Building CRISPR Gene Therapies for the Central Nervous System

CRISPR-Based Gene Editing Techniques in Pediatric Neurological Disorders

Recent Therapeutic Gene Editing Applications to Genetic Disorders

Application of novel CRISPR tools in brain therapy

The History, Use, and Challenges of Therapeutic Somatic Cell and Germline Gene Editing

Exploring the Potential and Challenges of CRISPR Delivery and Therapeutics for Genetic Disease Treatment

Delivering CRISPR: a review of the challenges and approaches

CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future

CRISPR/Cas and Gene Therapy: An Overview

Gene Editing Technology and Ethical Issues

CRISPR/Cas9-mediated genome editing: from basic research to gene therapy

Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies

Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders

In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications

Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease

Therapeutic applications of CRISPR/Cas9 system in gene therapy

Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies

Advances in CRISPR/Cas systems-based cell and gene therapy

RNA in Therapeutics: CRISPR in the Clinic

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases

Basic Principles and Clinical Applications of CRISPR-Based Genome Editing